Cargando…

Cross-sectional study on comorbidities and adverse events in patients with advanced and recurrent ovarian cancer in France

PURPOSE: The purpose of this study was to evaluate the prevalence of comorbidities and adverse events (AEs), and determine the treatment patterns according to platinum-sensitivity status in patients with advanced (stage IIIB–IV) or recurrent epithelial ovarian cancer (EOC). METHODS: A cross-sectiona...

Descripción completa

Detalles Bibliográficos
Autores principales:	Le Saux, Olivia, Taylor, Aliki, Chia, Victoria, Pillas, Demetris, Kaur, Moninder, Freyer, Gilles
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4629953/ https://www.ncbi.nlm.nih.gov/pubmed/26604823 http://dx.doi.org/10.2147/CLEP.S86429

Ejemplares similares

Stage-specific survival and recurrence in patients with cutaneous malignant melanoma in Europe – a systematic review of the literature
por: Svedman, Fernanda Costa, et al.
Publicado: (2016)

Subcutaneous trastuzumab: development of a new formulation for treatment of HER2-positive early breast cancer
por: Hamizi, Salima, et al.
Publicado: (2013)

Optimal management of breast cancer in the elderly patient: current perspectives
por: Le Saux, Olivia, et al.
Publicado: (2015)

Linezolid-Associated Neurologic Adverse Events in Patients with Multidrug-Resistant Tuberculosis, France
por: Jaspard, Marie, et al.
Publicado: (2020)

Burden of herpes zoster: the direct and comorbidity costs of herpes zoster events in hospitalized patients over 50 years in France
por: Blein, Cecile, et al.
Publicado: (2015)

Overcoming resistance to PARP inhibitor in epithelial ovarian cancer, are we ready?
por: Ray-Coquard, Isabelle, et al.
Publicado: (2020)

Digital PCR for Quantifying Norovirus in Oysters Implicated in Outbreaks, France
por: Polo, David, et al.
Publicado: (2016)

Cost analysis of adverse events associated with non-small cell lung cancer management in France
por: Chouaid, Christos, et al.
Publicado: (2017)

Does osteoarthritis modify the association between NSAID use and risk of comorbidities and adverse events?
por: Dell’Isola, Andrea, et al.
Publicado: (2022)

The Burden of Progressive Supranuclear Palsy on Patients, Caregivers, and Healthcare Systems by PSP Phenotype: A Cross-Sectional Study
por: Pillas, Demetris, et al.
Publicado: (2022)

Infarction Patterns and Recurrent Adverse Cerebrovascular Events in Moyamoya Disease
por: Yu, Shao-Chen, et al.
Publicado: (2022)

Preexisting comorbidities are associated with the mortality rate as well as the predialysis adverse events in incident dialysis patients
por: Lee, Min-Jeong, et al.
Publicado: (2021)

Human papillomavirus vaccine-associated premature ovarian insufficiency and related adverse events: data mining of Vaccine Adverse Event Reporting System
por: Gong, Li, et al.
Publicado: (2020)

Heterogeneity and Functions of Tumor-Infiltrating Antibody Secreting Cells: Lessons from Breast, Ovarian, and Other Solid Cancers
por: Lounici, Yasmine, et al.
Publicado: (2022)

Delphi Consensus Recommendations on Management of Dosing, Adverse Events, and Comorbidities in the Treatment of Idiopathic Pulmonary Fibrosis with Nintedanib
por: Rahaghi, Franck, et al.
Publicado: (2021)

Joint effects of recent stressful life events and adverse childhood experiences on perinatal comorbid anxiety and depression
por: Hou, Yanyan, et al.
Publicado: (2023)

Recurrent Cellulitis Revealing Helicobacter cinaedi in Patient on Ibrutinib Therapy, France
por: Roupie, Anne-Laure, et al.
Publicado: (2023)

Screening and treatment of familial hypercholesterolemia in a French sample of ambulatory care patients: A retrospective longitudinal cohort study
por: Ferrières, Jean, et al.
Publicado: (2021)

Peripheral Venous Catheter-Related Adverse Events: Evaluation from a Multicentre Epidemiological Study in France (the CATHEVAL Project)
por: Miliani, Katiuska, et al.
Publicado: (2017)

Large-scale mining disease comorbidity relationships from post-market drug adverse events surveillance data
por: Zheng, Chunlei, et al.
Publicado: (2018)

Early Childhood Development and Schooling Attainment: Longitudinal Evidence from British, Finnish and Philippine Birth Cohorts
por: Peet, Evan D., et al.
Publicado: (2015)

Periostin facilitates ovarian cancer recurrence by enhancing cancer stemness
por: Huang, Zhiqing, et al.
Publicado: (2023)

Genetic parameters of eventing horse competition in France
por: Ricard, Anne, et al.
Publicado: (2001)

Prediction of tumour response induced by chemotherapy using modelling of CA-125 kinetics in recurrent ovarian cancer patients
por: Wilbaux, M, et al.
Publicado: (2014)

Quantifying Neural Coding of Event Timing
por: Soteropoulos, Demetris S., et al.
Publicado: (2009)

Validity of the Liverpool Adverse Events Profile as a Screening Tool for Detecting Comorbid Depression or Anxiety Disorder in People with Epilepsy
por: Kwon, Oh-Young, et al.
Publicado: (2018)

Comorbidity Burden and Presence of Multiple Intracranial Lesions Are Associated with Adverse Events after Surgical Treatment of Patients with Brain Metastases
por: Schneider, Matthias, et al.
Publicado: (2020)

Mining comorbidities of opioid use disorder from FDA adverse event reporting system and patient electronic health records
por: Pan, Yiheng, et al.
Publicado: (2022)

Premature morbidity and mortality associated with potentially undiagnosed familial hypercholesterolemia in the general population
por: Ray, Kausik K., et al.
Publicado: (2023)

Microbiome transplantation and modulation of immune related adverse events
por: Smibert, Olivia C., et al.
Publicado: (2019)

Adverse Drug Events-based Tumor Stratification for Ovarian Cancer Patients Receiving Platinum Therapy
por: Wang, Chen, et al.
Publicado: (2015)

Chronic and Cumulative Adverse Life Events in Women with Primary Ovarian Insufficiency: An Exploratory Qualitative Study
por: Sun, Junyan, et al.
Publicado: (2022)

Dialysis Dependence Is Associated With Significantly Increased Odds of Perioperative Adverse Events After Geriatric Hip Fracture Surgery Even After Controlling for Demographic Factors and Comorbidities
por: Ottesen, Taylor D., et al.
Publicado: (2019)

Mathematical modeling of the early modeled CA-125 longitudinal kinetics (KELIM-PARP) as a pragmatic indicator of rucaparib efficacy in patients with recurrent ovarian carcinoma in ARIEL2 & STUDY 10
por: Colomban, Olivier, et al.
Publicado: (2023)

A Population-Based Cohort Study on Chronic Comorbidity Risk Factors for Adverse Dengue Outcomes
por: Lien, Chia-En, et al.
Publicado: (2021)

Completeness of adverse drug reactions reports of the Saudi adverse event reporting system
por: Alshammari, Thamir M., et al.
Publicado: (2015)

Challenges with the management of older patients with cancer during the COVID-19 pandemic
por: Falandry, Claire, et al.
Publicado: (2020)

Systematic Analysis of Adverse Event Reports for Sex Differences in Adverse Drug Events
por: Yu, Yue, et al.
Publicado: (2016)

Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients: Nivolumab-related serious/fatal adverse events
por: Zhao, Bin, et al.
Publicado: (2018)

Comorbidities as Risk Factors for Acute and Recurrent Erysipelas
por: Brishkoska-Boshkovski, Vesna, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_uvjq9gedob83ivjhs8nmtq0cll